Miller Insurance Services LLP was pleased to support and attend the recent meeting of the Cord Blood Association and representatives of European cord blood banks during the 3rd annual Cord Blood World Europe event hosted at the International Design Centre Islington. [Read more…]
The cord blood banking industry is a global industry composed of private banks, public banks, hybrid banks, a cord blood association in the U.S. and Brazil, and even global insurance plans to cover parents offered by CellPlan and Miller Insurance.
As the cord blood industry expands, the question becomes, what role with these cord blood associations play in supporting industry growth, collaboration, and education?
Cord Blood Associations, an Industry Trend
Cord Blood Associations first appeared with the formation of a cord blood association in Brazil in 2013, and subsequently, with the U.S. based Cord Blood Association in December of 2014.
The Associação Brasileira de Bancos de Células Tronco (ABBCT) was formed in Brazil in 2013, for purposes of bringing together cord blood industry leaders across academia, industry, and government. The association aims to promote transparency, as well as ethical and quality standards, across the Brazilian cord blood industry. For English speakers, the translation of “Associação Brasileira de Bancos de Células Tronco” means “The Brazilian Association of Stem Cell Banks.”
By December of 2014, a Cord Blood Association had also been formed in the United States, as well as an Advisory Committee to direct it, with four seats allocated for representatives from public cord blood banks, four seats allocated for representatives of private banks, and five seats allocated for cord blood industry “members at large.”
The association describes itself as an “international nonprofit organization to promote public and private banking and use of umbilical cord blood and related tissues for disease treatment and regenerative therapies.” Currently, the association disseminates most of its announcements through its LinkedIn page and through the website it launched in June of 2015, www.cb-association.org.
Role of a Cord Blood Association is to Support Industry Collaboration
The primary benefit of these cord blood industry associations is to allow cord blood banks, as well as industry representatives, to utilize collective resources, thereby more powerfully influencing public relations efforts, government funding decisions, press budgets, and more.
To further explain the operational purposes of the U.S. Cord Blood Association, an excellent video by Dr. Joanne Kurtzberg, is included below. As the first president of the Cord Blood Association and current director of the Carolinas Cord Blood Bank in Durham, North Carolina, she discusses the first cord blood transplant performed in France and the evolution of the cord blood community through 2015.
She also addresses the importance of cord blood industry collaboration.
Introduction to the Cord Blood Association, by Joanne Kurtzberg
To learn more, view the “Complete 2015-16 Global Cord Blood Banking Industry Report.”
Opinion Article: This is an article written by Ivan N. Rich of HemoGenix, Inc., Colorado Springs, CO, USA. It is an opinion piece that reflects views and positions of the author. It does not reflect the views of BioInformant Worldwide, LLC.
As a stem cell and cord blood industry blog, it is our role to spread discussion and allow a voice to varying opinions, perspectives, and areas of scientific expertise. If you have a reaction to this article, ask yourself, why am I reacting? How do I perceive current techniques for cord blood testing and assessment? If you have thoughts, they are encouraged in the comments section below.
November 24, 2015; HemoGenix, Inc. – The passage by voice vote of H.R. 2820, otherwise known as The Stem Cell Therapeutic and Research Reauthorization Act of 2015 through the U.S. House of Representatives  has been lauded by many in the cord blood community, including the Cord Blood Association (CBA) that promoted the bill. There is a good chance the Bill will become law, because health issues usually have bipartisan support. Although patients requiring a cord blood stem cell transplant have been helped by previous Bills, they have nevertheless not benefited from the principle purpose of this Bill, namely to provide high-quality cord blood stem cells for transplantation. [Read more…]